Schappell: UHS lacked electronic health records between 2011 and 2015
Matt Schappell · Matt Schappell on Healthcare Innovation: Investing in Tech-Driven Value-Based Care · Sep 5, 2025 · at 18:21
Matt Schappell, Principal at Frist Cressey Ventures, discusses the slow adoption of technology during his time working in hospital operations at UHS.
0:00 / 0:26exact quote · 26.3s
720p mp4 · rendered on demand · StarZero watermark
“At a time where the system I worked for UHS, you know, we didn't have an electronic health record. Which is crazy. People would think, oh my goodness, I didn't realize you worked there in the nineties, Matt, but I didn't. You know, this was in, in, you know, 20 11 2015, right? That there was not, you know, an electronic health record. So literally everybody's taking notes on, on, on pen and paper.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Matt Schappell
Schappell: EHR incumbents hinder innovation and interoperability in healthcare
“There needs to be interoperability within healthcare, and you've got a handful of folks who, Have a stronghold on the market and which is for better or for worse, but it's creating some challenges to adopt innovation, and to my point earlier, we are at a break…”
Schappell: 75% of healthcare is still delivered via fax machine
“I saw a statistic that 75% of healthcare is still delivered via fax machine.”
Schappell: Healthcare enterprise sales cycles usually take 12 to 18 months
“Sales cycles are, you know, we're high-fiving if you get a 12 month sales cycle. Everything else is, you know, usually 12 to 18 months before you get a decision maker to sign off and say, you know, let's, let's move forward.”
Schappell: AI agents and LLMs will enter clinical diagnosis and care delivery
“And so they're going to start to get into the diagnosis and delivery of care.”
Schappell: Frist Cressey Ventures will top $1B AUM upon closing Fund IV
“We are currently on our fourth fund. Once we close this fund, we'll be north of a billion in, in AUM.”
Frist Cressey writes $5M to $15M checks, skipping FDA-regulated deals
“So very practically we write five to fifteen million dollar checks and seed and series a stage businesses healthcare technology, healthcare services The things we don't do is anything that requires FDA approval. So think med device, life sciences, biotech, tho…”